A carregar...
Lenalidomide-Associated Immune Thrombocytopenia: A Case Report and Review of the Literature
Lenalidomide is indicated in the front-line management of multiple myeloma. More recently, it has been introduced for use in treating other hematologic malignancies. Although the drug is known to cause myelosuppression, there have been rare reports of lenalidomide-associated immune thrombocytopenia...
Na minha lista:
| Publicado no: | Case Rep Hematol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7676979/ https://ncbi.nlm.nih.gov/pubmed/33274089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8825618 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|